Therapeutic Potential of Biochanin-A Against Isoproterenol-Induced Myocardial Infarction in Rats

Author(s): Sangeethadevi Govindasami, Veera Venkata Sathibabu Uddandrao, Nivedha Raveendran, Vadivukkarasi Sasikumar*

Journal Name: Cardiovascular & Hematological Agents in Medicinal Chemistry
(Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents)

Volume 18 , Issue 1 , 2020

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Background: This study determined the effect of Biochanin A (BCA) on isoproterenol (ISO) induced Myocardial Infarction (MI) in male Wistar rats.

Methods: Animals (weighing 150-180 g) were divided into four groups, with six animals in each group and pretreated with BCA (10mg/kg Body Weight [BW]) and ɑ-tocopherol (60mg/kg BW) for 30 days; and ISO (20mg/kg BW) was administrated subcutaneously on the 31st and 32nd day.

Results: ISO-induced MI rats demonstrated the significant elevation of serum glutamic oxaloacetic transaminase, serum glutamic pyruvic transaminase, lactate dehydrogenase, creatine kinase-MB and cardiac troponin; however, concomitant pretreatment with BCA protected the rats from cardiotoxicity caused by ISO. Activities of antioxidant enzymes, such as superoxide dismutase, catalase, glutathione peroxidase, glutathione-S-transferase and glutathione reductase significantly reduced in the heart with ISO-induced MI. Pretreatment with BCA produced a marked reversal of these antioxidant enzymes related to MI-induced by ISO.

Conclusion: In conclusion, this study suggested that BCA exerts cardioprotective effects through modulating lipid peroxidation, enhancing antioxidants, and detoxifying enzyme systems.

Keywords: Biochanin A, cardiac markers, isoproterenol, myocardium, natural products, antioxidant enzymes.

[1]
Mc Namara, K.; Alzubaidi, H.; Jackson, J.K. Cardiovascular disease as a leading cause of death: How are pharmacists getting involved? Integr. Pharm. Res. Pract., 2019, 8, 1-11.
[http://dx.doi.org/10.2147/IPRP.S133088] [PMID: 30788283]
[2]
Shukla, S.K.; Sharma, S.B.; Singh, U.R.; Ahmad, S.; Maheshwari, A.; Misro, M.; Dwivedi, S. Eugenia jambolana pretreatment prevents isoproterenol-induced myocardial damage in rats: evidence from biochemical, molecular, and histopathological studies. J. Med. Food, 2014, 17(2), 244-253.
[http://dx.doi.org/10.1089/jmf.2013.2795] [PMID: 24325453]
[3]
Saravanan, G.; Ponmurugan, P.; Sathiyavathi, M.; Vadivukkarasi, S.; Sengottuvelu, S. Cardioprotective activity of Amaranthus viridis Linn: effect on serum marker enzymes, cardiac troponin and antioxidant system in experimental myocardial infarcted rats. Int. J. Cardiol., 2013, 165(3), 494-498.
[http://dx.doi.org/10.1016/j.ijcard.2011.09.005] [PMID: 21962802]
[4]
Slavich, M.; Patel, R.S. Coronary artery spasm: Current knowledge and residual uncertainties. Int. J. Cardiol. Heart Vasc., 2016, 10, 47-53.
[http://dx.doi.org/10.1016/j.ijcha.2016.01.003] [PMID: 28616515]
[5]
Wei, H.; Li, H.; Wan, S.P.; Zeng, Q.T.; Cheng, L.X.; Jiang, L.L.; Peng, Y.D. Cardioprotective effects of malvidin against isoproterenol-induced myocardial infarction in rats: A mechanistic study. Med. Sci. Monit., 2017, 23, 2007-2016.
[http://dx.doi.org/10.12659/MSM.902196] [PMID: 28445445]
[6]
Harini, R.; Ezhumalai, M.; Pugalendi, K.V. Antihyperglycemic effect of biochanin A, a soy isoflavone, on streptozotocin-diabetic rats. Eur. J. Pharmacol., 2012, 676(1-3), 89-94.
[http://dx.doi.org/10.1016/j.ejphar.2011.11.051] [PMID: 22178203]
[7]
Ko, W.C.; Lin, L.H.; Shen, H.Y.; Lai, C.Y.; Chen, C.M.; Shih, C.H. Biochanin a, a phytoestrogenic isoflavone with selective inhibition of phosphodiesterase 4, suppresses ovalbumin-induced airway hyperresponsiveness. Evid. Based Complement. Alternat. Med., 2011., 635058
[http://dx.doi.org/10.1155/2011/635058] [PMID: 21437195]
[8]
Azizi, R.; Goodarzi, M.T.; Salemi, Z. Effect of biochanin a on serum visfatin level of streptozocin-induced diabetic rats. Iran. Red Crescent Med. J., 2014, 16(9), e15424-e15428.
[http://dx.doi.org/10.5812/ircmj.15424] [PMID: 25593725]
[9]
Lu, M.P.; Wang, R.; Song, X.; Chibbar, R.; Wang, X.; Wu, L.; Meng, Q.H. Dietary soy isoflavones increase insulin secretion and prevent the development of diabetic cataracts in streptozotocin-induced diabetic rats. Nutr. Res., 2008, 28(7), 464-471.
[http://dx.doi.org/10.1016/j.nutres.2008.03.009] [PMID: 19083447]
[10]
Tappel, A.L. Vitamin E and free radical peroxidation of lipids. Ann. New York. Acad. Sci., 1972, 203, 12-28.
[http://dx.doi.org/10.1111/j.1749-6632.1972.tb27851.x] [PMID: 4572176]
[11]
Gey, K.F.; Puska, P.; Jordan, P.; Moser, U.K. Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. Am. J. Clin. Nutr., 1991, 53(1)(Suppl.), 326S-334S.
[http://dx.doi.org/10.1093/ajcn/53.1.326S] [PMID: 1985406]
[12]
Ohkawa, H.; Ohishi, N.; Yagi, K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem.,, 1979, 95(2), 351-358.
[http://dx.doi.org//10.1016/0003-2697(79)90738-3] [PMID: 36810]
[13]
Misra, H.P.; Fridovich, I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J. Biol. Chem., 1972, 247(10), 3170-3175.
[PMID: 4623845]
[14]
Sinha, A.K. Colorimetric assay of catalase. Anal. Biochem., 1972, 47(2), 389-394.
[http://dx.doi.org/10.1016/0003-2697(72)90132-7] [PMID: 4556490]
[15]
Rotruck, J.T.; Pope, A.L.; Ganther, H.E.; Swanson, A.B.; Hafeman, D.G.; Hoekstra, W.G. Selenium: biochemical role as a component of glutathione peroxidase. Science, 1973, 179(4073), 588-590.
[http://dx.doi.org/10.1126/science.179.4073.588] [PMID: 4686466]
[16]
Habig, W.H.; Jakoby, W.B. Assays for differentiation of glutathione S-transferases. Methods Enzymol., 1981, 77, 398-405.
[http://dx.doi.org/10.1016/S0076-6879(81)77053-8] [PMID: 7329316]
[17]
Ellman, G.L. Tissue sulfhydryl groups. Arch. Biochem. Biophys., 1959, 82(1), 70-77.
[http://dx.doi.org/10.1016/0003-9861(59)90090-6] [PMID: 13650640]
[18]
Carberg, I.; Mannerviek, B. Glutathione reductase levels in rat brain. J. Biol. Chem., 1975, 250, 90.
[19]
Goyal, S.N.; Sharma, C.; Mahajan, U.B.; Patil, C.R.; Agrawal, Y.O.; Kumari, S.; Arya, D.S.; Ojha, S. Protective effects of cardamom in isoproterenol-induced myocardial infarction in rats. Int. J. Mol. Sci., 2015, 16(11), 27457-27469.
[http://dx.doi.org/10.3390/ijms161126040] [PMID: 26593900]
[20]
Fleckenstein, A.; Janke, J.; Doering, H.J. Myocardial fiber necrosis due to intracellular Ca-overload: A new principle in cardiac pathophysiology. In: Recent Advances in Studies on Cardiac Structure and Metabolism; Fleckenstein, A.; Rona, G., Eds.; University Park Press: Baltimore, 1974, pp. 563-580.
[21]
Lehr, D. Healing of myocardial necrosis caused by sympathomimetic amines. Recent Adv. Stud. Cardiac Struct. Metab., 1972, 1, 526-550.
[PMID: 4681480]
[22]
Rahmathulla, S.M.; Sailaja, K.; Devi, K.L. Tribulus terrestris (I) protects heart and liver from beta adrenergic-stimulated cardiotoxicity: Biochemical and histological study in Wistar rats. Int. J. Drug Dev. Res., 2013, 5(1), 264-270.
[23]
Thirupurasundari, C.J.; Jayalakshmi, R.; Niranjali Devaraj, S. Liver architecture maintenance by tincture of Crataegus against isoproterenol-induced myocardially infarcted rats. J. Med. Food, 2005, 8(3), 400-404.
[http://dx.doi.org/10.1089/jmf.2005.8.400] [PMID: 16176155]
[24]
Rajadurai, M.; Prince, P.S. Comparative effects of Aegle marmelos extract and alpha-tocopherol on serum lipids, lipid peroxides and cardiac enzyme levels in rats with isoproterenol-induced myocardial infarction. Singapore Med. J., 2005, 46(2), 78-81.
[PMID: 15678289]
[25]
Ghoneim, M.A.; Hassan, A.I.; Mahmoud, M.G.; Asker, M.S. Protective effect of Adansonia digitata against isoproterenol-induced myocardial injury in rats. Anim. Biotechnol., 2016, 27(2), 84-95.
[http://dx.doi.org/10.1080/10495398.2015.1102147] [PMID: 26913549]
[26]
Alpert, J.S.; Thygesen, K.; Antman, E.; Bassand, J.P. Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J. Am. Coll. Cardiol., 2000, 36(3), 959-969.
[http://dx.doi.org/10.1016/S0735-1097(00)00804-4] [PMID: 10987628]
[27]
Al-Rasheed, N.M.; Al-Oteibi, M.M.; Al-Manee, R.Z.; Al-Shareef, S.A.; Al-Rasheed, N.M.; Hasan, I.H.; Mohamad, R.A.; Mahmoud, A.M. Simvastatin prevents isoproterenol-induced cardiac hypertrophy through modulation of the JAK/STAT pathway. Drug Des. Devel. Ther., 2015, 9, 3217-3229.
[PMID: 26150695]
[28]
Bates, K.J.; Hall, E.M.; Fahie-Wilson, M.N.; Kindler, H.; Bailey, C.; Lythall, D.; Lamb, E.J. Circulating immunoreactive cardiac troponin forms determined by gel filtration chromatography after acute myocardial infarction. Clin. Chem., 2010, 56(6), 952-958.
[http://dx.doi.org/10.1373/clinchem.2009.133546] [PMID: 20378771]
[29]
Adamcova, M.; Sterba, M.; Simunek, T.; Potacova, A.; Popelova, O.; Mazurova, Y.; Gersl, V. Troponin as a marker of myocardiac damage in drug-induced cardiotoxicity. Expert Opin. Drug Saf., 2005, 4(3), 457-472.
[http://dx.doi.org/10.1517/14740338.4.3.457] [PMID: 15934853]
[30]
Khalil, M.I.; Ahmmed, I.; Ahmed, R.; Tanvir, E.M.; Afroz, R.; Paul, S.; Gan, S.H.; Alam, N. Amelioration of isoproterenol-induced oxidative damage in rat myocardium by Withania somnifera leaf extract. BioMed Res. Int., 2015, 2015624159
[http://dx.doi.org/10.1155/2015/624159] [PMID: 26539517]


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 18
ISSUE: 1
Year: 2020
Page: [31 - 36]
Pages: 6
DOI: 10.2174/1871525718666200206114304
Price: $65

Article Metrics

PDF: 23
HTML: 1